Business Daily from THE HINDU group of publications Saturday, Jan 06, 2007 ePaper |
|
|
|
|
|
|
|
Corporate
-
Alliances & Joint Ventures Biocon forms venture with Neopharma of UAE Our Bureau
Ms Kiran Mazumdar Shaw, CMD, Biocon
Bangalore , Jan. 5 Biocon Ltd has announced a 50:50 joint venture with Neopharma, the Abu Dhabi-based outfit of NRI healthcare figure, Dr B.R. Shetty. The step marks Biocon's foray into the rich GCC (Gulf cooperation Council) market of six Arab States - UAE, Bahrain, Kuwait, Saudi Arabia, Oman and Qatar. The new entity to be incorporated in Abu Dhabi will initially take at least 10 of Biocon's life-saving drug products to these countries. "We would like to be in that market soon, probably by the next fiscal (April 2007)," Ms Kiran Mazumdar Shaw, CMD of the Bangalore-based biotech major, told Business Line, but did not divulge the investment details. The range will include Biocon's generic and novel therapeutics to treat cancer, diabetes, auto-immune and cardiovascular diseases, immunosuppressants. The second phase will see manufacturing activity also. Biocon's insulin is already in the West Asian market but through a licensing arrangement. "We want to take more of our products there and also change that model" and be involved directly in marketing operations, she said. As per an MoU they signed on Thursday, the new company will have a dedicated sales force trained by Biocon and operating directly under Biocon's control, she said. Dr Shetty is recognised for his role in healthcare in the UAE through a chain of hospitals, pharmacy chains and an integrated pharmaceutical distribution network. The tie-up would give Biocon a foothold in a new and promising region, while enlarging Neopharma's range into biotechnology. A Biocon release quoting Dr B.R. Shetty, Chairman and CEO of The Neopharma Group, said, "Neopharma's foray into biotechnology will catalyse a wave of biotechnology initiatives in the region." "The GCC region is an important market for Biocon and the joint venture with Neopharma is an important milestone for Biocon's global foray," the company said quoting Ms Mazumdar-Shaw.
More Stories on : Alliances & Joint Ventures | Bio-tech & Genetics
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2007, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|